A nationwide phase II study of delayed local treatment for children with high-risk neuroblastoma: The Japan Children’s Cancer Group Neuroblastoma Committee Trial JN-H-11
Pediatr Blood Cancer. 2024 Apr 5:e30976. doi: 10.1002/pbc.30976. Online ahead of print. ABSTRACT PURPOSE: Survival rates of patients with high-risk neuroblastoma are unacceptable. A time-intensified …